From trial and error to AI-driven discovery: The future of drugs and materials
In recent years, artificial intelligence (AI) in the pharmaceutical industry has gained significant traction, especially in the drug discovery field, as this technology can identify and develop new medications, helping AI researchers and pharmaceutical scientists eliminate the traditional and labor-intensive techniques of trial-and-error experimentation and high-throughput screening. The...
0 Comments 0 Shares 521 Views
Sponsored
Sponsored
Sponsored